Both in Pharmaceuticals
Avalyn Pharma vs UroGen Pharma
Over the past year AVLN returned −20.6% and URGN returned −39.2%; their daily moves had a correlation of 0.07.
AVLN −20.6% URGN −39.2%Growth of $1, one year, split-adjusted
| Metric | AVLN | URGN |
|---|---|---|
| Price | $26.67 | $25.73 |
| Market cap | $1.18B | $1.26B |
| Today | −2.91% | −10.47% |
| 1 month | +4.5% | −36.8% |
| 6 months | — | −3.2% |
| Year to date | — | +9.9% |
| 1 year | — | +29.9% |
| Revenue growth (YoY) | — | +199.2% |
| Gross margin | — | 90.9% |
| Net margin | — | −19.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 6.7× |
| Net cash | $337.6M | -$85.1M |
| Dividend yield | — | — |
| Volatility (60d) | — | 57.8% |
| Short % of float | 11.6% | 12.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).